Doing well by doing good

Sapient manages an unique pool of capital that is a double bottom-line evergreen fund.

• It focuses on BOTH Return on Capital and Return on Mission.
• The investment returns are reinvested into the fund to create a self-sustaining capital base.
• The patient impact is measured through number of lives saved and medicines made.
• It has deliberately constructed a “hub and spoke” infrastructure constellation bespoke to unique cost and time demands of Orphan drug development.